CIBC Private Wealth Group
EXAS

CIBC Private Wealth Group’s Exact Sciences EXAS Stock Holding History

CIBC Private Wealth Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$335K Sell
3,296
-1,037
-24% -$83.3K ﹤0.01% 996
2025
Q3 		$237K Buy
4,333
+1,399
+48% +$69.9K ﹤0.01% 1108
2025
Q2 		$156K Sell
2,934
-7
-0.2% -$356 ﹤0.01% 1220
2025
Q1 		$119K Sell
2,941
-416
-12% -$21.1K ﹤0.01% 1292
2024
Q4 		$190K Sell
3,357
-426
-11% -$26.5K ﹤0.01% 1175
2024
Q3 		$258K Sell
3,783
-213
-5% -$12K ﹤0.01% 1081
2024
Q2 		$181K Sell
3,996
-74
-2% -$4.07K ﹤0.01% 1144
2024
Q1 		$287K Buy
4,070
+120
+3% +$7.59K ﹤0.01% 990
2023
Q4 		$292K Buy
3,950
+29
+0.7% +$1.9K ﹤0.01% 944
2023
Q3 		$267K Buy
3,921
+1,694
+76% +$144K ﹤0.01% 912
2023
Q2 		$209K Buy
+2,227
New +$174K ﹤0.01% 831
2022
Q3 		– Sell
-30
Closed -$1K – 1000
2022
Q2 		$1K Sell
30
-6,484
-100% -$347K ﹤0.01% 1166
2022
Q1 		$455K Sell
6,514
-251
-4% -$18.3K ﹤0.01% 770
2021
Q4 		$527K Sell
6,765
-244,804
-97% -$21.6M ﹤0.01% 766
2021
Q3 		$24M Buy
251,569
+37,700
+18% +$3.98M 0.06% 222
2021
Q2 		$26.6M Sell
213,869
-4,969
-2% -$593K 0.06% 218
2021
Q1 		$28.8M Sell
218,838
-8,718
-4% -$1.19M 0.07% 194
2020
Q4 		$30.1M Sell
227,556
-4,324
-2% -$523K 0.08% 181
2020
Q3 		$23.6M Buy
231,880
+3,447
+2% +$298K 0.07% 185
2020
Q2 		$19.9M Sell
228,433
-11,434
-5% -$914K 0.1% 149
2020
Q1 		$13.9M Sell
239,867
-7,071
-3% -$574K 0.06% 209
2019
Q4 		$22.8M Sell
246,938
-9,037
-4% -$794K 0.07% 191
2019
Q3 		$23.1M Sell
255,975
-755,246
-75% -$86.1M 0.08% 182
2019
Q2 		$119M Sell
1,011,221
-38,241
-4% -$3.85M 0.42% 74
2019
Q1 		$90.9M Buy
1,049,462
+140,825
+15% +$12M 0.35% 93
2018
Q4 		$57.3M Sell
908,637
-190,930
-17% -$13.1M 0.26% 111
2018
Q3 		$86.8M Sell
1,099,567
-7,569
-0.7% -$494K 0.33% 92
2018
Q2 		$66.2M Buy
1,107,136
+481,230
+77% +$25.9M 0.27% 108
2018
Q1 		$25.2M Buy
625,906
+506,404
+424% +$24.7M 0.11% 178
2017
Q4 		$6.28M Buy
+119,502
New +$6.38M 0.03% 329

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

CIBC Private Wealth Group's EXAS Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its Exact Sciences (EXAS) stake by 24% in Q4 2025, selling an estimated $83.3K and leaving 3,296 shares worth $335K. The position accounts for ﹤0.01% of the portfolio, ranked #996.

CIBC Private Wealth Group first reported a position in EXAS in Q4 2017 and has held it in 30 quarters since. The position peaked at $119M in Q2 2019. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • CIBC Private Wealth Group held 3,296 shares of Exact Sciences worth $335K as of Q4 2025.
  • CIBC Private Wealth Group sold 1,037 Exact Sciences shares in Q4 2025, an estimated $83.3K.
  • Exact Sciences made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #996 holding.
  • CIBC Private Wealth Group first reported a position in Exact Sciences in Q4 2017 and has held it in 30 quarters since.
  • CIBC Private Wealth Group's Exact Sciences position peaked at $119M in Q2 2019.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.